News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
93,233 Results
Type
Article (3566)
Company Profile (15)
Press Release (89652)
Multimedia
Podcasts (3)
Webinars (1)
Section
Business (35267)
Career Advice (81)
Deals (7389)
Drug Delivery (13)
Drug Development (11586)
Employer Resources (11)
FDA (2153)
Job Trends (2405)
News (54417)
Policy (3550)
Tag
2027 Pharm Country Standard (1)
Academia (210)
Accelerated approval (4)
Allergies (24)
Alliances (3895)
ALS (16)
Alzheimer's disease (256)
Antibody-drug conjugate (ADC) (44)
Approvals (2263)
Artificial intelligence (33)
Autoimmune disease (21)
Automation (3)
Bankruptcy (41)
Best Places to Work (2096)
BIOSECURE Act (2)
Biosimilars (8)
Biotechnology (13)
Bladder cancer (57)
Brain cancer (9)
Breast cancer (114)
Cancer (797)
Cardiovascular disease (68)
Career advice (75)
Career pathing (2)
CAR-T (34)
CDC (6)
Cell therapy (93)
Cervical cancer (3)
Clinical research (10904)
Collaboration (144)
Compensation (234)
Complete response letters (6)
COVID-19 (333)
CRISPR (23)
C-suite (57)
Cystic fibrosis (19)
Data (1225)
Depression (8)
Diabetes (80)
Diagnostics (1060)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (2)
Drug discovery (11)
Drug pricing (15)
Drug shortages (4)
Duchenne muscular dystrophy (19)
Earnings (30066)
Editorial (2)
Employer branding (1)
Employer resources (11)
Events (9728)
Executive appointments (46)
FDA (2810)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (10)
Funding (201)
Gene editing (38)
Generative AI (3)
Gene therapy (73)
GLP-1 (158)
Government (511)
Grass and pollen (3)
Guidances (267)
Healthcare (2778)
HIV (17)
Huntington's disease (15)
IgA nephropathy (17)
Immunology and inflammation (38)
Immuno-oncology (8)
Indications (21)
Infectious disease (393)
Inflammatory bowel disease (14)
Inflation Reduction Act (1)
Influenza (24)
Intellectual property (24)
Interviews (3)
IPO (5117)
IRA (2)
Job creations (401)
Job search strategy (65)
JPM (6)
Kidney cancer (2)
Labor market (14)
Layoffs (74)
Leadership (1)
Legal (714)
Liver cancer (16)
Longevity (1)
Lung cancer (110)
Lymphoma (115)
Machine learning (4)
Management (4)
Manufacturing (86)
MASH (35)
Medical device (2170)
Medtech (2176)
Mergers & acquisitions (2476)
Metabolic disorders (205)
Multiple sclerosis (37)
NASH (3)
Neurodegenerative disease (48)
Neuropsychiatric disorders (18)
Neuroscience (446)
NextGen: Class of 2026 (741)
Non-profit (409)
Now hiring (7)
Obesity (90)
Opinion (15)
Ovarian cancer (37)
Pain (28)
Pancreatic cancer (18)
Parkinson's disease (47)
Partnered (7)
Patents (31)
Patient recruitment (60)
Peanut (8)
People (3146)
Pharmaceutical (4)
Pharmacy benefit managers (1)
Phase 1 (2550)
Phase 2 (4579)
Phase 3 (4632)
Pipeline (1646)
Policy (11)
Postmarket research (389)
Preclinical (649)
Press Release (1)
Prostate cancer (27)
Psychedelics (7)
Radiopharmaceuticals (32)
Rare diseases (123)
Real estate (495)
Recruiting (5)
Regulatory (2921)
Reports (8)
Research institute (252)
Resumes & cover letters (10)
Rett syndrome (3)
RNA editing (2)
RSV (36)
Schizophrenia (31)
Series A (26)
Series B (23)
Service/supplier (1)
Sickle cell disease (10)
Special edition (5)
Spinal muscular atrophy (45)
Sponsored (2)
Startups (317)
Stomach cancer (3)
Supply chain (13)
Tariffs (8)
The Weekly (3)
Vaccines (121)
Venture capital (13)
Weight loss (63)
Women's health (10)
Worklife (1)
Date
Today (13)
Last 7 days (94)
Last 30 days (295)
Last 365 days (5510)
2026 (402)
2025 (5542)
2024 (6356)
2023 (7430)
2022 (8781)
2021 (9252)
2020 (8629)
2019 (6303)
2018 (4686)
2017 (4378)
2016 (3603)
2015 (4636)
2014 (2960)
2013 (1917)
2012 (2236)
2011 (2566)
2010 (2398)
Location
Africa (63)
Alabama (13)
Alaska (1)
Arizona (35)
Arkansas (2)
Asia (5364)
Australia (852)
California (1864)
Canada (561)
China (147)
Colorado (102)
Connecticut (77)
Delaware (85)
Europe (14276)
Florida (326)
Georgia (57)
Idaho (2)
Illinois (110)
India (6)
Indiana (114)
Iowa (1)
Japan (88)
Kansas (23)
Kentucky (5)
Louisiana (8)
Maine (41)
Maryland (185)
Massachusetts (1527)
Michigan (46)
Minnesota (90)
Missouri (11)
Montana (4)
Nebraska (2)
Nevada (18)
New Hampshire (11)
New Jersey (675)
New Mexico (2)
New York (522)
North Carolina (258)
Northern California (974)
Ohio (62)
Oregon (4)
Pennsylvania (389)
Puerto Rico (3)
Rhode Island (1)
South America (114)
South Carolina (2)
Southern California (722)
Tennessee (19)
Texas (278)
United States (7006)
Utah (48)
Vermont (1)
Virginia (31)
Washington D.C. (3)
Washington State (136)
Wisconsin (10)
Wyoming (1)
93,233 Results for "75".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Altimmune Announces Closing of $75 Million Registered Direct Offering of Common Stock
January 30, 2026
·
4 min read
Press Releases
Altimmune Announces Pricing of $75 Million Registered Direct Offering of Common Stock
January 28, 2026
·
4 min read
Press Releases
Protara Announces Closing of $75 Million Public Offering
December 9, 2025
·
3 min read
Press Releases
Protara Announces Pricing of $75 Million Public Offering
December 5, 2025
·
4 min read
Press Releases
Beacon Therapeutics Announces Closing of Oversubscribed Series C Financing for Over $75 Million
January 8, 2026
·
5 min read
Press Releases
Contineum Therapeutics Announces Proposed $75.0 Million Public Offering
December 12, 2025
·
4 min read
Press Releases
National Kidney Foundation Marks 75 Years of Transforming Kidney Health
December 2, 2025
·
3 min read
Press Releases
Inquis Medical Announces $75 Million Series C Financing to Scale Commercial Adoption of its AVENTUS Thrombectomy System
January 13, 2026
·
2 min read
Press Releases
The Mark Foundation for Cancer Research Announces 2026 Emerging Leader Awards, Committing $3.75 Million to Next-Generation Oncology Breakthroughs
January 14, 2026
·
4 min read
Press Releases
MoonLake Immunotherapeutics Announces Pricing of $75 Million Underwritten Offering
November 5, 2025
·
4 min read
1 of 9,324
Next
